Albemarle
Print | Share


<< Back
Albemarle continues double digit growth in third quarter

CHARLOTTE, N.C., Nov. 8, 2017 /PRNewswire/ --

Albemarle Corp. Logo. (PRNewsFoto/Albemarle Corporation)

Third quarter 2017 highlights:

  • Third quarter net sales were $754.9 million, an increase of 15% over the prior year
  • Third quarter earnings were $118.7 million, or $1.06 per diluted share
  • Third quarter adjusted EBITDA was $209.4 million, an increase of 11% over the prior year; adjusted diluted earnings per share from continuing operations of $1.08, an increase of 19% over the prior year
  • Delivered double digit growth despite the impact of hurricane Harvey, which reduced adjusted EBITDA by $11 million and adjusted diluted earnings per share by $0.07
  • Announced technology innovation to increase efficiency of lithium extraction in Chile under existing pumping rates by 50% and requested related quota increase from CORFO

 


Three Months Ended


Nine Months Ended


September 30,


September 30,

In thousands, except per share amounts

2017


2016


2017


2016

Net sales

$

754,866



$

654,010



$

2,214,187



$

1,980,548


Net income from continuing operations

$

130,193



$

114,512



$

306,539



$

428,334


Net income attributable to Albemarle Corporation

$

118,670



$

128,220



$

273,216



$

41,585


Adjusted EBITDA

$

209,383



$

188,329



$

639,700



$

570,833


Diluted earnings per share attributable to Albemarle
Corporation

$

1.06



$

1.13



$

2.43



$

0.37


   Non-operating pension and OPEB items(a)

(0.01)





(0.02)




   Non-recurring and other unusual items(b)

0.02



(0.02)



0.84



(0.75)


   Discontinued operations(c)



(0.20)





3.16


Adjusted diluted earnings per share from continuing
operations(d)

$

1.08



$

0.91



$

3.26



$

2.78



See accompanying notes (a) through (d) to the condensed consolidated financial information and non-GAAP reconciliations.

Albemarle Corporation (NYSE: ALB) reported third quarter 2017 net sales of $754.9 million, earnings of $118.7 million and adjusted EBITDA of $209.4 million.

"In the third quarter, we delivered the seventh consecutive quarter of year over year revenue growth excluding divested businesses," said Luke Kissam, Albemarle's Chairman, President and CEO. "Our revenue, adjusted EBITDA and adjusted diluted EPS grew by 15%, 11% and 19%, respectively, compared to third quarter of 2016. Lithium led the way and is now forecasted to grow adjusted EBITDA by over 50% versus 2016. Our Wave 1 expansion projects in lithium remain on schedule, and our work related to lithium yield improvements and exploration of new resources is producing preliminary results meeting our expectations."

Outlook

Based on our strong performance through the third quarter of 2017, we are increasing our guidance as outlined below:


Previous Outlook


Current Outlook

Net sales

$2.90 - $3.05 billion


$3.00 - $3.05 billion

Adjusted EBITDA

$835 - $875 million


$860 - $875 million

Adjusted EPS (per diluted share)

$4.20 - $4.40


$4.40 - $4.50

Results

Third quarter 2017 earnings were $118.7 million, or $1.06 per diluted share, compared to $128.2 million, or $1.13 per diluted share in the third quarter 2016. Earnings per share and adjusted earnings per share were both negatively impacted by hurricane Harvey by $0.07 per diluted share. Excluding the impact of hurricane Harvey, the decrease in 2017 was primarily related to income from discontinued operations of $0.20 per diluted share in 2016, partially offset by earnings growth of our Lithium and Advanced Materials and Bromine Specialties segments. Third quarter 2017 adjusted EBITDA increased by $21.1 million, or 11.2%, compared to the prior year. Third quarter 2017 adjusted net income from continuing operations was $120.6 million, or $1.08 per diluted share, compared to $102.7 million, or $0.91 per diluted share, for third quarter 2016, an increase of 18.7%. See notes to the condensed consolidated financial information for further details. The Company reported net sales of $754.9 million in third quarter 2017, up 15.4% from net sales of $654.0 million in the third quarter of 2016, driven by the favorable impact of higher sales volumes and pricing impacts of our Lithium and Advanced Materials and Bromine segments and favorable currency exchange impacts.

For the nine-month period ended September 30, 2017, earnings were $273.2 million, or $2.43 per diluted share, compared to $41.6 million, or $0.37 per diluted share for the nine-month period ended September 30, 2016. Earnings per share and adjusted earnings per share were both negatively impacted by hurricane Harvey by $0.07 per diluted share. Excluding the impact of hurricane Harvey, the increase in 2017 was primarily driven by a loss from discontinued operations of $3.16 per diluted share in 2016, as well as earnings growth in our Lithium and Advanced Materials and Bromine Specialties segments. For the nine-month period ended September 30, 2017, adjusted EBITDA was $639.7 million, up 12.1% compared to $570.8 million for the same period in 2016. For the nine-month period ended September 30, 2017, adjusted net income from continuing operations was $366.0 million, or $3.26 per diluted share, compared to $315.0 million, or $2.78 per diluted share, for the same period in 2016, an increase of 17.3%. See notes to the condensed consolidated financial information for further details. The Company reported net sales for the nine-month period ended September 30, 2017 of $2.21 billion, up 11.8% from net sales of $1.98 billion, driven by the favorable impact of higher sales volumes in each of our three reportable segments and pricing impacts of our Lithium and Advanced Materials segment, partially offset by the impact of the divestiture of the minerals-based flame retardants and specialty chemicals business and unfavorable currency exchange impacts.

Quarterly Segment Results

Lithium and Advanced Materials reported net sales of $343.6 million in the third quarter of 2017, an increase of 42.9% from third quarter 2016 net sales of $240.4 million. The $103.1 million increase in net sales as compared to prior year was primarily due to favorable pricing impacts, increased sales volumes and $1.6 million of favorable currency exchange impacts. Adjusted EBITDA for Lithium and Advanced Materials was $130.2 million, an increase of 42.0% from third quarter 2016 results of $91.7 million. The $38.5 million increase in adjusted EBITDA as compared to the prior year was primarily due to favorable pricing impacts and increased sales volumes, partially offset by Lithium growth spending, a $3.9 million negative impact from hurricane Harvey on Performance Catalyst Solutions ("PCS") and $0.2 million of unfavorable currency exchange impacts.

Bromine Specialties reported net sales of $212.9 million in the third quarter of 2017, an increase of 9.5% from third quarter 2016 net sales of $194.5 million. The $18.4 million increase in net sales as compared to the prior year was primarily due to increased sales volumes related to flame retardants and favorable pricing impacts. Adjusted EBITDA for Bromine Specialties was $63.9 million, an increase of 23.4% from third quarter 2016 results of $51.8 million. The $12.1 million increase in adjusted EBITDA as compared to the prior year was primarily due to higher volume and favorable pricing impacts, partially offset by higher selling, general and administrative costs and a $2.7 million negative impact from hurricane Harvey.

Refining Solutions reported net sales of $170.3 million in the third quarter of 2017, a decrease of 10.6% from net sales of $190.5 million in the third quarter of 2016. The $20.2 million decrease in net sales as compared to the prior year was primarily due to lower sales volumes and unfavorable pricing impacts due to customer and product mix, partially offset by $1.4 million of favorable currency exchange impacts. Adjusted EBITDA for Refining Solutions was $43.1 million in the third quarter of 2017, a decrease of 33.6% from third quarter 2016 results of $65.0 million. The $21.8 million decrease in adjusted EBITDA as compared to the prior year was primarily due to unfavorable volume and mix impacts, as well as a $4.8 million negative impact from hurricane Harvey.

All Other net sales were $28.0 million in the third quarter of 2017, a decrease of 0.9% from net sales of $28.3 million in the third quarter of 2016. The $0.3 million decrease in net sales as compared to the prior year was primarily due to lower sales volumes partially offset by favorable pricing for the fine chemistry services business. All Other adjusted EBITDA was $0.3 million in the third quarter of 2017, a decrease of 94.4% from third quarter 2016 results of $5.5 million. The $5.2 million decrease in adjusted EBITDA as compared to the prior year was primarily due to a $2.9 million gain in the fair value of our investment in private equity securities for the three-month period ended September 30, 2016 and the impact of the divestiture of $1.3 million. Excluding these items, adjusted EBITDA decreased $1.0 million due to lower volume and slightly higher costs in the fine chemistry services business.

Corporate Results

Corporate adjusted EBITDA was a loss of $28.2 million in the third quarter of 2017 compared to a loss of $25.6 million in the third quarter of 2016. The decrease in Corporate adjusted EBITDA was primarily due to $2.1 million of unfavorable currency exchange impacts.

Income Taxes

Our effective income tax rates for the third quarter of 2017 and 2016 of 14.3% and 11.1%, respectively, are influenced by non-recurring, other unusual and non-operating pension and OPEB items (see notes to the condensed consolidated financial information). Our adjusted effective income tax rates, which exclude non-recurring, other unusual and non-operating pension and OPEB items, were 17.0% and 18.2% for the third quarter of 2017 and 2016, respectively, and continue to be influenced by the level and geographic mix of income. The increase in the effective tax rate in the third quarter of 2017 compared to 2016 was impacted by a variety of factors, primarily stemming from the discrete tax benefit in 2016 related to accrual to return adjustments of $6.1 million driven mainly by adjustments to our Chilean entity. Our effective income tax rates for the nine months ended September 30, 2017 and 2016 were 17.6% and 13.8%, respectively, and our adjusted effective income tax rates for the nine months ended September 30, 2017 and 2016 were 19.5% and 18.5%, respectively. The effective tax rate in 2016 was driven down by a variety of factors, primarily low tax gains from the sale of the minerals-based flame retardant business.

Cash Flow

Our cash from operations was approximately $74.8 million for the nine months ended September 30, 2017, down $379.3 million versus the same period in 2016 primarily due to changes in working capital, including the payment of approximately $255 million in taxes related to the sale of the Chemetall Surface Treatment business in 2017. We had $1.05 billion in cash and cash equivalents at September 30, 2017, as compared to $2.27 billion at December 31, 2016. During the first nine months of 2017, cash on hand, cash provided by operations and net borrowings funded $753.2 million of debt repayments, primarily related to the senior notes, $187.5 million of capital expenditures for plant, machinery and equipment, dividends to shareholders of $105.2 million and a $250.0 million accelerated share repurchase program. As a result of the program, we received and retired approximately 2.3 million shares of our common stock in the second quarter of 2017.

Earnings Call

The Company's performance for the third quarter ended September 30, 2017 will be discussed on a conference call at 9:00 AM Eastern time on November 9, 2017. The call can be accessed by dialing 888-713-4199 (International Dial-In # 617-213-4861), and entering conference ID 31692592. The Company's earnings presentation and supporting material can be accessed through Albemarle's website under Investors at www.albemarle.com.

About Albemarle

Albemarle Corporation (NYSE: ALB), headquartered in Charlotte, NC, is a global specialty chemicals company with leading positions in lithium, bromine and refining catalysts. We power the potential of companies in many of the world's largest and most critical industries, from energy and communications to transportation and electronics. Working side-by-side with our customers, we develop value-added, customized solutions that make them more competitive. Our solutions combine the finest technology and ingredients with the knowledge and know-how of our highly experienced and talented team of operators, scientists and engineers.

Discovering and implementing new and better performance-based sustainable solutions is what motivates all of us. We think beyond business-as-usual to drive innovations that create lasting value. Albemarle employs approximately 4,500 people and serves customers in approximately 100 countries. We regularly post information to www.albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations, SEC filings and other information regarding our company, its businesses and the markets it serves.

Forward-Looking Statements

Some of the information presented in this press release, the conference call and discussions that follow, including, without limitation, product development, changes in productivity, market trends, price, expected growth and earnings, input costs, surcharges, tax rates, stock repurchases, dividends, cash flow generation, costs and cost synergies, portfolio diversification, economic trends, outlook and all other information relating to matters that are not historical facts may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from the views expressed. Factors that could cause actual results to differ materially include, without limitation: changes in economic and business conditions; changes in financial and operating performance of our major customers and industries and markets served by us; the timing of orders received from customers; the gain or loss of significant customers; competition from other manufacturers; changes in the demand for our products; limitations or prohibitions on the manufacture and sale of our products; availability of raw materials; changes in the cost of raw materials and energy; changes in our markets in general; fluctuations in foreign currencies; changes in laws and government regulation impacting our operations or our products; the occurrence of regulatory proceedings, claims or litigation; the occurrence of cybersecurity breaches, terrorist attacks, industrial accidents, natural disasters or climate change; the inability to maintain current levels of product or premises liability insurance or the denial of such coverage; political unrest affecting the global economy; political instability affecting our manufacturing operations or joint ventures; changes in accounting standards; the inability to achieve results from our global manufacturing cost reduction initiatives as well as our ongoing continuous improvement and rationalization programs; changes in the jurisdictional mix of our earnings and changes in tax laws and rates; changes in monetary policies, inflation or interest rates; volatility and substantial uncertainties in the debt and equity markets; technology or intellectual property infringement; decisions we may make in the future; the ability to successfully execute, operate and integrate acquisitions and divestitures; and the other factors detailed from time to time in the reports we file with the SEC, including those described under "Risk Factors" in our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q. These forward-looking statements speak only as of the date of this press release. We assume no obligation to provide any revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.

 

 

Albemarle Corporation and Subsidiaries
Consolidated Statements of Income
(In Thousands Except Per Share Amounts) (Unaudited)



Three Months Ended


Nine Months Ended


September 30,


September 30,


2017


2016


2017


2016

Net sales

$

754,866



$

654,010



$

2,214,187



$

1,980,548


Cost of goods sold(a)(b)

479,077



415,038



1,411,216



1,250,938


Gross profit

275,789



238,972



802,971



729,610


Selling, general and administrative expenses(a)(b)

105,582



86,302



329,269



254,988


Research and development expenses(b)

21,763



21,012



63,423



61,384


Gain on sales of businesses, net(b)







(122,298)


Acquisition and integration related costs(b)



6,749





44,337


Operating profit

148,444



124,909



410,279



491,199


Interest and financing expenses(b)

(15,792)



(15,946)



(98,895)



(46,860)


Other (expenses) income, net(b)

(3,008)



2,990



(6,512)



740


Income from continuing operations before income taxes
and equity in net income of unconsolidated investments

129,644



111,953



304,872



445,079


Income tax expense(b)

18,495



12,394



53,596



61,535


Income from continuing operations before equity in net
income of unconsolidated investments

111,149



99,559



251,276



383,544


Equity in net income of unconsolidated investments (net of
tax)

19,044



14,953



55,263



44,790


Net income from continuing operations

130,193



114,512



306,539



428,334


Income (loss) from discontinued operations (net of tax)(c)



23,185





(357,843)


Net income

130,193



137,697



306,539



70,491


Net income attributable to noncontrolling interests

(11,523)



(9,477)



(33,323)



(28,906)


Net income attributable to Albemarle Corporation

$

118,670



$

128,220



$

273,216



$

41,585


Basic earnings (loss) per share:








Continuing operations

$

1.07



$

0.93



$

2.46



$

3.56


Discontinued operations



0.21





(3.19)



$

1.07



$

1.14



$

2.46



$

0.37


Diluted earnings (loss) per share:








Continuing operations

$

1.06



$

0.93



$

2.43



$

3.53


Discontinued operations



0.20





(3.16)



$

1.06



$

1.13



$

2.43



$

0.37


Weighted-average common shares outstanding – basic

110,476



112,429



111,049



112,343


Weighted-average common shares outstanding – diluted

111,975



113,448



112,456



113,131



See accompanying notes to the condensed consolidated financial information.

 

Albemarle Corporation and Subsidiaries
Condensed Consolidated Balance Sheets
(In Thousands) (Unaudited)



September 30,


December 31,


2017


2016

ASSETS




Cash and cash equivalents

$

1,045,339



$

2,269,756


Other current assets

1,281,985



1,036,862


Total current assets

2,327,324



3,306,618


Property, plant and equipment

4,167,065



3,910,522


Less accumulated depreciation and amortization

1,682,780



1,550,382


Net property, plant and equipment

2,484,285



2,360,140


Other assets and intangibles

2,711,691



2,494,449


Total assets

$

7,523,300



$

8,161,207


LIABILITIES AND EQUITY




Current portion of long-term debt

$

382,358



$

247,544


Other current liabilities

720,659



892,559


Total current liabilities

1,103,017



1,140,103


Long-term debt

1,407,171



2,121,718


Other noncurrent liabilities

559,506



544,043


Deferred income taxes

414,034



412,739


Albemarle Corporation shareholders' equity

3,898,819



3,795,062


Noncontrolling interests

140,753



147,542


Total liabilities and equity

$

7,523,300



$

8,161,207



See accompanying notes to the condensed consolidated financial information.

 

Albemarle Corporation and Subsidiaries

Selected Consolidated Cash Flow Data

(In Thousands) (Unaudited)



Nine Months Ended


September 30,


2017


2016

Cash and cash equivalents at beginning of year

$

2,269,756



$

213,734


Cash and cash equivalents at end of period

$

1,045,339



$

233,599


Sources of cash and cash equivalents:




Net income

$

306,539



$

70,491


Cash proceeds from divestitures, net

6,857



310,599


Proceeds from borrowings of long-term debt

27,000




Other borrowings, net

79,203




Dividends received from unconsolidated investments and nonmarketable securities

11,900



34,982


Proceeds from exercise of stock options

7,011



6,779


Uses of cash and cash equivalents:




Working capital changes

(398,913)



(79,684)


Capital expenditures

(187,519)



(141,301)


Acquisitions, net of cash acquired

(45,406)




Cash payments related to acquisitions and other



(81,988)


Repayments of long-term debt

(753,209)



(382,730)


Repurchases of common stock

(250,000)




Repayments of other borrowings, net



(9,026)


Pension and postretirement contributions

(9,607)



(13,649)


Dividends paid to shareholders

(105,205)



(101,061)


Fees related to early extinguishment of debt

(46,959)




Dividends paid to noncontrolling interests

(27,791)



(23,873)


Non-cash and other items:




Depreciation and amortization

144,087



176,499


Gain on sales of businesses, net



(122,298)


Gain on acquisition

(6,025)




Pension and postretirement expense

67



7,911


Loss on early extinguishment of debt

52,801




Deferred income taxes

4,677



404,728


Equity in net income of unconsolidated investments (net of tax)

(55,263)



(46,224)



See accompanying notes to the condensed consolidated financial information.

 

Albemarle Corporation and Subsidiaries
Consolidated Summary of Segment Results
(In Thousands) (Unaudited)



Three Months Ended


Nine Months Ended


September 30,


September 30,


2017


2016


2017


2016

Net sales:








Lithium and Advanced Materials

$

343,557



$

240,424



$

945,791



$

689,950


Bromine Specialties

212,923



194,496



636,059



597,912


Refining Solutions

170,275



190,453



539,904



539,044


All Other

28,021



28,272



91,144



150,987


Corporate

90



365



1,289



2,655


Total net sales

$

754,866



$

654,010



$

2,214,187



$

1,980,548










Adjusted EBITDA:








Lithium and Advanced Materials

$

130,218



$

91,719



$

382,789



$

260,861


Bromine Specialties

63,936



51,807



194,499



179,977


Refining Solutions

43,120



64,960



142,777



181,620


All Other

306



5,470



7,906



14,810


Corporate(a)

(28,197)



(25,627)



(88,271)



(66,435)


Total adjusted EBITDA

$

209,383



$

188,329



$

639,700



$

570,833


 

Lithium and Advanced Materials - details by product category:



Three Months Ended


Nine Months Ended


September 30,


September 30,


2017


2016


2017


2016

Net sales:








Lithium

$

269,238



$

166,406



$

729,288



$

460,679


PCS

74,319



74,018



216,503



229,271


Total Lithium and Advanced Materials

$

343,557



$

240,424



$

945,791



$

689,950










Adjusted EBITDA:








Lithium

$

112,944



$

68,637



$

327,996



$

196,617


PCS

17,274



23,082



54,793



64,244


Total Lithium and Advanced Materials

$

130,218



$

91,719



$

382,789



$

260,861



See accompanying notes to the condensed consolidated financial information and non-GAAP reconciliations below.

Notes to the Condensed Consolidated Financial Information

(a)   Non-operating pension and OPEB items, consisting of MTM actuarial gains/losses, settlements/curtailments, interest cost and expected return on assets, are not allocated to our reportable segments and are included in the Corporate category. Although non-operating pension and OPEB items are included in Cost of goods sold and Selling, general and administrative expenses in accordance with GAAP, we believe that these components of pension cost are mainly driven by market performance, and we manage these separately from the operational performance of our businesses. Non-operating pension and OPEB items included in Cost of goods sold and Selling, general and administrative expenses were as follows (in millions):


Three Months Ended


Nine Months Ended


September 30,


September 30,


2017


2016


2017


2016

Cost of goods sold:








Interest cost and expected return on assets, net

$

(0.1)



$

(0.2)



$

(0.4)



$

(0.5)


Total

$

(0.1)



$

(0.2)



$

(0.4)



$

(0.5)










Selling, general and administrative expenses:








Interest cost and expected return on assets, net

$

(0.9)



$

(0.1)



$

(2.7)



$

(0.3)


Total

$

(0.9)



$

(0.1)



$

(2.7)



$

(0.3)


(b)   In addition to the non-operating pension and OPEB items disclosed above, we have identified certain other items from continuing operations and excluded them from our adjusted net income calculation for the periods presented. A listing of these items, as well as a detailed description of each follows below (per diluted share):


Three Months Ended


Nine Months Ended


September 30,


September 30,


2017


2016


2017


2016

Utilization of inventory markup(1)

$



$



$

0.16



$


Write-off of research and development fixed assets(2)



0.01





0.01


Restructuring and other, net(3)





0.11




Acquisition and integration related costs(4)

0.02



0.03



0.18



0.26


Gain on sales of businesses, net(5)







(1.02)


Gain on sales of properties, net(6)



(0.01)





(0.01)


Gain on acquisition(7)

0.01





(0.05)




Loss on extinguishment of debt(8)





0.34




Multiemployer plan shortfall contributions(9)

0.01





0.04




Other(10)

(0.01)





0.04




Discrete tax items(11)

(0.01)



(0.05)



0.02



0.01


Total non-recurring and other unusual items

$

0.02



$

(0.02)



$

0.84



$

(0.75)


(1)   In connection with the acquisition of the lithium hydroxide and lithium carbonate conversion business of Jiangxi Jiangli New Materials Science and Technology Co. Ltd. ("Jiangli New Materials"), the Company valued inventory purchased from Jiangli New Materials at fair value, which resulted in a markup of the underlying net book value of the inventory totaling approximately $23.1 million. The inventory markup was expensed over the estimated remaining selling period. For the three and nine months ended September 30, 2017, $0.6 million and $23.1 million ($0.2 million and $17.8 million after income taxes, or less than $0.01 and $0.16 per share), respectively, was included in Cost of goods sold related to the utilization of the inventory markup.   

(2)   Included in Research and development expenses for the three and nine months ended September 30, 2016 is a loss of $1.4 million ($0.6 million after income taxes, or $0.01 per share) resulting from the write-off of research and development fixed assets in China.

(3)   The nine months ended September 30, 2017 included restructuring costs in each of our reportable segments at several locations, primarily at our Lithium site in Germany. These restructuring costs are included in the consolidated statements of income as follows (in millions):


Nine Months Ended


September 30, 2017

Restructuring and other costs:


Cost of goods sold

$

2.9


Selling, general and administrative expenses

8.4


Research and development expenses

5.8


Total

$

17.1


Total restructuring and other costs, after income taxes

$

13.0


Total restructuring and other costs, per diluted share

$

0.11


(4)   Acquisition and integration related costs for the three and nine months ended September 30, 2017 primarily resulted from the acquisition of Jiangli New Materials. For the three and nine months ended September 30, 2016, acquisition and integration related costs of $6.3 million and $42.4 million, respectively, related to integration costs resulting from the acquisition of Rockwood, and $0.4 million and $1.9 million, respectively, were in connection with other significant projects. Acquisition and integration related costs are included in the consolidated statements of income as follows (in millions):


Three Months Ended


Nine Months Ended


September 30,


September 30,


2017


2016


2017


2016

Acquisition and integration related costs:








Cost of goods sold

$

1.8



$



$

12.5



$


Selling, general and administrative expenses

3.8





13.9




Acquisition and integration related costs



6.7





44.3


Total

$

5.6



$

6.7



$

26.4



$

44.3


Total acquisition and integration related costs,
after income taxes

$

2.6



$

3.1



$

20.1



$

29.5


Total acquisition and integration related costs,
per diluted share

$

0.02



$

0.03



$

0.18



$

0.26


(5)   Included in Gain on sales of businesses, net, for the nine months ended September 30, 2016 is $11.5 million ($11.3 million after income taxes, or $0.10 per share) related to the sale of the metal sulfides business and $112.3 million ($105.8 million after income taxes, or $0.93 per share) related to the sale of the minerals-based flame retardants and specialty chemicals businesses. In addition, Gain on sales of businesses, net, for the nine months ended September 30, 2016 includes a loss of $1.5 million, or $0.01 per share, on the sale of our wafer reclaim business.

(6)   Included in Other (expenses) income, net for the three and nine months ended September 30, 2016 is a net gain of $0.9 million ($0.4 million after income taxes, or $0.01 per share) on the sales of properties.

(7)   Included in Other (expenses) income, net, for the nine months ended September 30, 2017 is a gain of $6.0 million ($5.4 million after income taxes, or $0.05 per share) related to the acquisition of the remaining 50% interest in the Sales de Magnesio Ltda. joint venture in Chile. During the three months ended September 30, 2017 we adjusted this gain to reduce it by $1.4 million ($0.6 million after income taxes, or $0.01 per share). The gain was calculated based on the difference between the purchase price and the book value of the investment.

(8)  Included in Interest and financing expenses for the nine months ended September 30, 2017 is a loss on early extinguishment of debt of $52.8 million ($38.1 million after income taxes, or $0.34 per share) related to the tender premiums, fees, unamortized discounts and unamortized deferred financings costs from the redemption of the 3.00% Senior notes, €307.0 million of the 1.875% Senior notes and $174.7 million of the 4.50% Senior notes.

(9)  Included in Selling, general and administrative expenses for the nine months ended September 30, 2017 is $2.0 million ($1.4 million after income taxes, or $0.01 per share) for increased capital reserve contributions to a multiemployer plan, which is subject to a financial improvement plan. In addition, for the three and nine months ended September 30, 2017, capital reserve contributions for this multiemployer plan of $1.6 million and $4.6 million ($0.6 million and $2.8 million after income taxes, or $0.01 and $0.03 per share), respectively, included in Other (expenses) income, net, have been made to indemnify previously divested businesses.

(10) Other adjustments for the three months ended September 30, 2017 included amounts recorded in:

  • Cost of goods sold - $1.3 million reversal of deferred income related to an abandoned project at an unconsolidated investment.
  • Other (expenses) income, net - $1.1 million related to a reversal of a liability associated with the previous disposal of a property, partially offset by the revision of tax indemnification expenses of $0.7 million primarily related to the filing of tax returns for a previously disposed business.

After income taxes, these net gains totaled $1.1 million, or $0.01 per share.

Other adjustments for the nine months ended September 30, 2017 included amounts recorded in:

  • Cost of goods sold - $1.3 million reversal of deferred income related to an abandoned project at an unconsolidated investment.
  • Selling, general and administrative expenses - $1.0 million related to a reversal of an accrual recorded as part of purchase accounting from a previous acquisition.
  • Other (expenses) income, net - $3.2 million of asset retirement obligation charges related to the revision of an estimate at a site formerly owned by Albemarle, a loss of $2.1 million associated with the previous disposal of a business, final settlement claims associated with the previous disposal of a business of $2.0 million and the revision of tax indemnification expenses of $1.9 million primarily related to the filing of tax returns and a competent authority agreement for a previously disposed business, partially offset by a reversal of a liability associated with the previous disposal of a property of $1.1 million.

After income taxes, these net charges totaled $4.5 million, or $0.04 per share.

(11) Included in Income tax expense for the three and nine months ended September 30, 2017 are discrete net tax (benefits) expenses of ($0.4) million, or ($0.01) per share, and $2.7 million, or $0.02 per share, respectively. The net benefit for the three months is primarily related to a $2.2 million benefit from the excess tax benefits realized from stock-based compensation arrangements, and $1.0 million from the release of valuation allowances due to a foreign restructure plan, partially offset by expenses from accrual to return and rate changes of $2.8 million. The net expense for the nine months is primarily related to foreign rate changes of $14.8 million and accrual to return adjustments of $7.9 million, partially offset by a $10.8 million benefit from the release of valuation allowances due to a foreign restructuring plan, $2.3 million from release of unrecognized tax benefits, and $6.9 million benefit from excess tax benefits realized from stock-based compensation arrangements. Included in Income tax expense for the three months ended September 30, 2016 are benefits of $5.5 million, or $0.05 per share respectively, related mainly to foreign provision to return adjustments. Included in Income tax expense for the nine months ended September 30, 2016 are expense items of $1.6 million, or $0.01 per share respectively, related mainly to a change in the Company's assertion over book and tax basis differences of a foreign entity, changes in valuation allowances necessary because of the announced divestiture of the Chemetall Surface Treatment business, and decreased by foreign tax rate changes and provision to return adjustments.

(c)  On June 17, 2016, the Company entered into a definitive agreement to sell the Chemetall Surface Treatment business to BASF SE. On December 14, 2016, the Company closed the sale of this business for cash proceeds of approximately $3.1 billion, net of purchase price adjustments. Income (loss) from discontinued operations (net of tax) in the consolidated statements of income for the nine months ended September 30, 2016 includes a discrete non-cash charge of $381.5 million due to a change in the Company's assertion over book and tax basis differences related to a U.S. entity being sold, as well as a discrete non-cash charge of $29.8 million related to a change in the Company's assertion over reinvestment of foreign undistributed earnings.

(d)  Totals may not add due to rounding.

Additional Information

It should be noted that adjusted net income from continuing operations, adjusted diluted earnings per share attributable to Albemarle Corporation, adjusted diluted earnings per share from continuing operations, non-operating pension and OPEB items per diluted share, non-recurring and other unusual items per diluted share, adjusted effective income tax rates, EBITDA, adjusted EBITDA, EBITDA margin and adjusted EBITDA margin are financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in the United States, or GAAP. These non-GAAP measures should not be considered as alternatives to net income attributable to Albemarle Corporation ("earnings"). These measures are presented here to provide additional useful measurements to review our operations, provide transparency to investors and enable period-to-period comparability of financial performance. The Company's chief operating decision maker uses these measures to assess the ongoing performance of the Company and its segments, as well as for business and enterprise planning purposes.

A description of other non-GAAP financial measures that we use to evaluate our operations and financial performance, and reconciliation of these non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, can be found in the Investors section of our website at www.albemarle.com, under "Non-GAAP Reconciliations" under "Financials." Also, see the following pages for supplemental reconciliations of the non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP. The Company does not provide a reconciliation of forward looking non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, as the Company is unable to estimate significant non-recurring or unusual items without unreasonable effort. The amounts and timing of these items are uncertain and could be material to the Company's results calculated in accordance with GAAP.

ALBEMARLE CORPORATION AND SUBSIDIARIES
Non-GAAP Reconciliations
(In Thousands)
(Unaudited)

See below for a reconciliation of adjusted net income from continuing operations, EBITDA and adjusted EBITDA, the non-GAAP financial measures, to Net income attributable to Albemarle Corporation ("earnings"), the most directly comparable financial measure calculated and reported in accordance with GAAP. Adjusted earnings is defined as earnings before the non-recurring, other unusual and non-operating pension and OPEB items as listed below. EBITDA is defined as earnings before discontinued operations, interest and financing expenses, income taxes, and depreciation and amortization. Adjusted EBITDA is defined as EBITDA and the non-recurring, other unusual and non-operating pension and OPEB items as listed below.


Three Months Ended


Nine Months Ended


September 30,


September 30,


2017


2016


2017


2016

Net income attributable to Albemarle Corporation

$

118,670



$

128,220



$

273,216



$

41,585


Add back:








(Income) loss from discontinued operations (net of tax)



(23,185)





357,843


Earnings from continuing operations

118,670



105,035



273,216



399,428


Add back:








Non-operating pension and OPEB items from continuing operations
(net of tax)

(694)



(154)



(2,093)



(260)


Non-recurring and other unusual items from continuing operations
(net of tax)

2,575



(2,170)



94,918



(84,218)


Adjusted net income from continuing operations

$

120,551



$

102,711



$

366,041



$

314,950










Adjusted diluted earnings per share from continuing operations

$

1.08



$

0.91



$

3.26



$

2.78










Weighted-average common shares outstanding – diluted

111,975



113,448



112,456



113,131










Net income attributable to Albemarle Corporation

$

118,670



$

128,220



$

273,216



$

41,585


Add back:








(Income) loss from discontinued operations (net of tax)



(23,185)





357,843


Interest and financing expenses

15,792



15,946



98,895



46,860


Income tax expense

18,495



12,394



53,596



61,535


Depreciation and amortization

49,895



47,974



144,087



141,288


EBITDA

202,852



181,349



569,794



649,111


Non-operating pension and OPEB items

(1,028)



(231)



(3,144)



(779)


Non-recurring and other unusual items (excluding items associated
with interest expense)

7,559



7,211



73,050



(77,499)


Adjusted EBITDA

$

209,383



$

188,329



$

639,700



$

570,833










Net sales

$

754,866



$

654,010



$

2,214,187



$

1,980,548


EBITDA margin

26.9

%


27.7

%


25.7

%


32.8

%

Adjusted EBITDA margin

27.7

%


28.8

%


28.9

%


28.8

%

See below for a reconciliation of adjusted EBITDA on a segment basis, the non-GAAP financial measure, to Net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reporting in accordance with GAAP.


Lithium
and
Advanced
Materials


Bromine
Specialties


Refining
Solutions


Reportable
Segments
Total


All
Other


Corporate


Consolidated
Total


% of
Net
Sales

Three months ended September 30, 2017:
















Net income (loss) attributable to Albemarle
Corporation

$

103,199



$

53,760



$

34,392



$

191,351



$

(1,776)



$

(70,905)



$

118,670



15.7

%

Depreciation and amortization

26,136



10,176



9,978



46,290



2,082



1,523



49,895



6.6

%

Non-recurring and other unusual items

883





(1,250)



(367)





7,926



7,559



1.0

%

Interest and financing expenses











15,792



15,792



2.1

%

Income tax expense











18,495



18,495



2.4

%

Non-operating pension and OPEB items











(1,028)



(1,028)



(0.1)

%

Adjusted EBITDA

$

130,218



$

63,936



$

43,120



$

237,274



$

306



$

(28,197)



$

209,383



27.7

%

















Three months ended September 30, 2016:
















Net income (loss) attributable to Albemarle
Corporation

$

66,166



$

41,621



$

55,981



$

163,768



$

3,806



$

(39,354)



$

128,220



19.6

%

Depreciation and amortization

25,553



10,186



8,979



44,718



1,664



1,592



47,974



7.3

%

Non-recurring and other unusual items











7,211



7,211



1.1

%

Interest and financing expenses











15,946



15,946



2.4

%

Income tax expense











12,394



12,394



1.9

%

Income from discontinued operations (net of tax)











(23,185)



(23,185)



(3.5)

%

Non-operating pension and OPEB items











(231)



(231)



%

Adjusted EBITDA

$

91,719



$

51,807



$

64,960



$

208,486



$

5,470



$

(25,627)



$

188,329



28.8

%

















Nine months ended September 30, 2017:
















Net income (loss) attributable to Albemarle
Corporation

$

292,655



$

164,193



$

115,329



$

572,177



$

1,622



$

(300,583)



$

273,216



12.3

%

Depreciation and amortization

74,157



30,306



28,698



133,161



6,284



4,642



144,087



6.5

%

Non-recurring and other unusual items
(excluding items associated with interest
expense)

15,977





(1,250)



14,727





58,323



73,050



3.3

%

Interest and financing expenses











98,895



98,895



4.5

%

Income tax expense











53,596



53,596



2.4

%

Non-operating pension and OPEB items











(3,144)



(3,144)



(0.1)

%

Adjusted EBITDA

$

382,789



$

194,499



$

142,777



$

720,065



$

7,906



$

(88,271)



$

639,700



28.9

%

















Nine months ended September 30, 2016:
















Net income (loss) attributable to Albemarle
Corporation

$

186,373



$

150,221



$

154,767



$

491,361



$

133,012



$

(582,788)



$

41,585



2.1

%

Depreciation and amortization

74,488



29,756



26,853



131,097



5,629



4,562



141,288



7.1

%

Non-recurring and other unusual items









(123,831)



46,332



(77,499)



(3.9)

%

Interest and financing expenses











46,860



46,860



2.4

%

Income tax expense











61,535



61,535



3.1

%

Loss from discontinued operations (net of
tax)











357,843



357,843



18.1

%

Non-operating pension and OPEB items











(779)



(779)



%

Adjusted EBITDA

$

260,861



$

179,977



$

181,620



$

622,458



$

14,810



$

(66,435)



$

570,833



28.8

%

 


Lithium


PCS


Total
Lithium
and
Advanced
Materials

Three months ended September 30, 2017:






Net income attributable to Albemarle Corporation

$

89,745



$

13,454



$

103,199


Depreciation and amortization

22,316



3,820



26,136


Non-recurring and other unusual items

883





883


Adjusted EBITDA

$

112,944



$

17,274



$

130,218








Three months ended September 30, 2016:






Net income attributable to Albemarle Corporation

$

46,848



$

19,318



$

66,166


Depreciation and amortization

21,789



3,764



25,553


Adjusted EBITDA

$

68,637



$

23,082



$

91,719








Nine months ended September 30, 2017:






Net income attributable to Albemarle Corporation

$

249,178



$

43,477



$

292,655


Depreciation and amortization

62,841



11,316



74,157


Non-recurring and other unusual items

15,977





15,977


Adjusted EBITDA

$

327,996



$

54,793



$

382,789








Nine months ended September 30, 2016:






Net income attributable to Albemarle Corporation

$

133,323



$

53,050



$

186,373


Depreciation and amortization

63,294



11,194



74,488


Adjusted EBITDA

$

196,617



$

64,244



$

260,861


See below for a reconciliation of the adjusted effective income tax rate, the non-GAAP financial measure, to the effective income tax rate, the most directly comparable financial measure calculated and reporting in accordance with GAAP.


Income from
continuing
operations before
income taxes and
equity in net income
of unconsolidated
investments


Income tax expense


Effective income tax
rate

Three months ended September 30, 2017:






As reported

$

129,644



$

18,495



14.3

%

Non-recurring, other unusual and non-operating pension and OPEB
items from continuing operations

6,531



4,650




As adjusted

$

136,175



$

23,145



17.0

%







Three months ended September 30, 2016:






As reported

$

111,953



$

12,394



11.1

%

Non-recurring, other unusual and non-operating pension and OPEB
items from continuing operations

6,980



9,304




As adjusted

$

118,933



$

21,698



18.2

%







Nine months ended September 30, 2017:






As reported

$

304,872



$

53,596



17.6

%

Non-recurring, other unusual and non-operating pension and OPEB
items from continuing operations

122,707



29,882




As adjusted

$

427,579



$

83,478



19.5

%







Nine months ended September 30, 2016:






As reported

$

445,079



$

61,535



13.8

%

Non-recurring, other unusual and non-operating pension and OPEB
items from continuing operations

(78,278)



6,200




As adjusted

$

366,801



$

67,735



18.5

%

 

View original content with multimedia:http://www.prnewswire.com/news-releases/albemarle-continues-double-digit-growth-in-third-quarter-300552406.html

SOURCE Albemarle Corporation

Matt Juneau, 225.388.7940